SCHEMBL8048917

SCHEMBL8048917

O=C(/C=C/c1ccc(Cl)cc1)Nc1cccc(C(=O)O)c1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTB4R Q15722 1/20 0.76
MMP1 P03956 8/20 0.67
MMP2 P08253 8/20 0.67
MMP9 P14780 8/20 0.67
MAOB P27338 3/20 0.67
EGFR P00533 3/20 0.67
TRPV1 Q8NER1 2/20 0.67
MAOA P21397 2/20 0.67
MEN1 O00255 3/20 0.65
KMT2A Q03164 3/20 0.65
MAPT P10636 2/20 0.65
NPC1 O15118 2/20 0.65
HDAC6 Q9UBN7 1/20 0.65
NPSR1 Q6W5P4 1/20 0.65
ALDH1A1 P00352 1/20 0.65
TP53 P04637 1/20 0.65
CYP3A4 P08684 1/20 0.65
CYP2C9 P11712 1/20 0.65
TSHR P16473 1/20 0.65
MAPK1 P28482 1/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8048920 1.00 LTB4R (0.76) LTB4RMMP1MMP2MMP9MAOB
SCHEMBL8049032 0.89 LTB4R (0.84) LTB4RMMP1MMP2MMP9MAOB
SCHEMBL8049033 0.89 LTB4R (0.84) LTB4RMMP1MMP2MMP9MAOB
SCHEMBL8060583 0.88 MAOB (0.73) LTB4RMMP1MMP2MMP9MAOB
SCHEMBL8060586 0.88 MAOB (0.73) LTB4RMMP1MMP2MMP9MAOB
SCHEMBL8059959 0.87 LTB4R (0.69) LTB4RMMP1MMP2MMP9MAOB
SCHEMBL8059954 0.87 LTB4R (0.69) LTB4RMMP1MMP2MMP9MAOB
SCHEMBL8059640 0.86 LTB4R (0.76) LTB4RMMP1MMP2MMP9MAOB
SCHEMBL8060331 0.86 LTB4R (0.76) LTB4RMMP1MMP2MMP9MAOB
SCHEMBL8060333 0.86 LTB4R (0.76) LTB4RMMP1MMP2MMP9MAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6127392-A A MUSCLE RELAXANT FOR TREATMENT OF DISORDERS ASSOCIATED WITH SMOOTH MUSCLE CONTRACTION VIA POTASSIUM CHANNEL AND CHLORIDE CHANNEL MODULATION; INOTROPIC AGENT AMERICAN HOME PRODUCTS CORPORATION (US) 2000-10-03 US disclosed
US-6046239-A USED IN THE TREATMENT OF DISORDERS ASSOCIATED WITH SMOOTH MUSCLE CONTRACTION, VIA POTASSIUM CHANNEL AND CHLORIDE CHANNEL MODULATION SUCH AS URINARY INCONTINENCE, ASTHMA, ANGINA, PREMATURE LABOR, CONGESTIVE HEART FAILURE AMERICAN HOME PRODUCTS CORPORATION (US) 2000-04-04 US disclosed